Validity and Reliability of the Turkish Form of the Knowledge Assessment Scales for Dementia and Urinary Incontinence

April 17, 2026 updated by: Atahan TURHAN, Kirsehir Ahi Evran Universitesi
The primary aim of the study was to determine the Turkish version of the "Validity and Reliability of the Knowledge Assessment Scales for Dementia and Urinary Incontinence in Community Older People". The secondary aim of the study was to measure the knowledge level of dementia and urinary incontinence in the community-living elderly population.

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

230

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Merkez
      • Kırşehir, Merkez, Turkey (Türkiye), 40100
        • Kirsehir Ahi Evran University Physical Therapy and Rehabilitation Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

The study will be conducted at Kırşehir Ahi Evran University Physical Therapy and Rehabilitation Center. All patient relatives and hospital staff who meet the inclusion criteria will be included in the study. These participants will be reached through face-to-face communication or online methods (sms, e-mail), and a list of participants will be prepared and evaluations will be made.

Description

Inclusion Criteria:

  1. Being 55 years of age or older
  2. Knowing how to read and write
  3. Being willing to participate in the study

Exclusion Criteria:

1. Having any chronic illness that would prevent urinary retention and dementia level

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Study Group
Other: There is no intervention in the study.
There is no intervention in the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge Assessment Scales for Dementia and Urinary Incontinence in Community Older People
Time Frame: 20 weeks
The scale was developed by Hui Sun et al. to assess the level of knowledge about dementia and urinary incontinence among elderly individuals living in the community. The original language of the scale is Chinese and was translated into English by the researchers. The two knowledge assessment scales for dementia and urinary incontinence consist of 12 and 8 items, respectively. The model fit indicators of both met the criteria of confirmatory factor analysis. Cronbach'sα was 0.82 and 0.70, respectively. The completion rate and completion time of the two scales were 83.51% and 4.22±1.90 minutes.
20 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF)
Time Frame: 20 weeks
The severity of incontinence and its impact on the quality of life of the participants will be assessed with the ICIQ-SF. The ICIQ-SF consists of 6 items that question the type and frequency of urinary incontinence and the impact of incontinence on the individual's quality of life. The total score that can be obtained from the scale varies between 0-21. An increase in the total score indicates an increase in the severity of incontinence.
20 weeks
Incontinence Quality of Life Questionnaire (I-QOL)
Time Frame: 20 weeks
The participants' quality of life will be assessed with the I-QOL, which was specifically developed for urinary incontinence. The I-QOL is a scale consisting of 22 items and 3 subgroups that questions thoughts such as anxiety and depression that develop due to incontinence and the reflection of these thoughts on life. The total score that can be obtained from the scale varies between 0-100, and higher scores indicate better quality of life.
20 weeks
Standardize Mini Mental State (SMMS)
Time Frame: 20 weeks
SMMS will be used to assess the cognitive status of the participants. SMMS is a scale consisting of 11 items and 5 subgroups that measure cognitive functions. The total score that can be obtained from the scale varies between 0-30, and it is recommended that those who score 24 and below be evaluated for dementia.
20 weeks
Lawton-Brody Instrumental Activities of Daily Living Scale (IADL)
Time Frame: 20 weeks
The independence of the participants in their daily living activities will be assessed with the IADL. The IADL is a scale consisting of 8 items that assess instrumental daily living activities. The total score that can be obtained from the scale varies between 0-24, and an increase in the score indicates an increase in the level of independence.
20 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Kirsehir Ahi Evran Universitesi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 8, 2024

Primary Completion (Estimated)

July 10, 2026

Study Completion (Estimated)

August 10, 2026

Study Registration Dates

First Submitted

December 26, 2024

First Submitted That Met QC Criteria

December 26, 2024

First Posted (Actual)

January 3, 2025

Study Record Updates

Last Update Posted (Actual)

April 22, 2026

Last Update Submitted That Met QC Criteria

April 17, 2026

Last Verified

August 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KAEU-T.ATAHAN-007

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dementia

Clinical Trials on There is no intervention in the study.

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Oman

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe